SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$273.48

Market cap

$103.13B

P/E Ratio

49.36

Dividend/share

$2.47

EPS

$5.54

Enterprise value

$113.63B

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; ...

Highlights
SYK's net income is up by 48% since the previous quarter and by 30% year-on-year
Stryker's EPS has increased by 48% from the previous quarter and by 29% YoY
SYK's P/E is 29% above its 5-year quarterly average of 38.8 but 6% below its last 4 quarters average of 53.4
SYK's quick ratio is down by 41% YoY and by 4.8% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.stryker.com/
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK
Market
Shares outstanding
377.1M
Market cap
$103.13B
Enterprise value
$113.63B
Valuations
Price to earnings (P/E)
49.36
Price to book (P/B)
7.46
Price to sales (P/S)
6.34
EV/EBIT
45.82
EV/EBITDA
39.95
EV/Sales
6.99
Earnings
Revenue
$16.25B
EBIT
$2.48B
EBITDA
$2.84B
Free cash flow
$2.97B
Per share
EPS
$5.54
Free cash flow per share
$7.89
Book value per share
$36.68
Revenue per share
$43.1
TBVPS
$41.48
Balance sheet
Total assets
$33.7B
Total liabilities
$19.88B
Debt
$12.74B
Equity
$13.82B
Working capital
$4.78B
Liquidity
Debt to equity
0.92
Current ratio
2.12
Quick ratio
1.19
Net debt/EBITDA
3.69
Margins
EBITDA margin
17.5%
Gross margin
64.4%
Net margin
12.8%
Operating margin
17.2%
Efficiency
Return on assets
6.2%
Return on equity
15.6%
Return on invested capital
11.4%
Return on capital employed
8.4%
Return on sales
15.3%
Dividend
Dividend yield
0.9%
DPS
$2.47
Payout ratio
44.5%

SYK stock price

How has the Stryker stock price performed over time
Intraday
-1.14%
1 week
1.92%
1 month
0.02%
1 year
33.4%
YTD
11.61%
QTD
5.29%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$16.25B
Gross profit
$10.46B
Operating income
$2.8B
Net income
$2.08B
Gross margin
64.4%
Net margin
12.8%
SYK's net income is up by 48% since the previous quarter and by 30% year-on-year
The operating income has grown by 37% since the previous quarter and by 28% year-on-year
SYK's net margin is up by 33% from the previous quarter and by 12% YoY
Stryker's operating margin has increased by 24% QoQ and by 11% YoY

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
P/E
49.36
P/B
7.46
P/S
6.34
EV/EBIT
45.82
EV/EBITDA
39.95
EV/Sales
6.99
Stryker's EPS has increased by 48% from the previous quarter and by 29% YoY
SYK's P/E is 29% above its 5-year quarterly average of 38.8 but 6% below its last 4 quarters average of 53.4
SYK's P/B is 28% above its 5-year quarterly average of 5.9 and 13% above its last 4 quarters average of 6.7
SYK's equity is up by 8% year-on-year and by 2.4% since the previous quarter
The stock's price to sales (P/S) is 28% more than its 5-year quarterly average of 5.0 and 7% more than its last 4 quarters average of 6.0
The company's revenue rose by 15% YoY and by 10% QoQ

Efficiency

How efficient is Stryker business performance
The ROA has grown by 44% from the previous quarter and by 15% YoY
The ROE rose by 44% QoQ and by 24% YoY
Stryker's ROIC has increased by 41% from the previous quarter and by 6% YoY
Stryker's ROS has increased by 30% from the previous quarter and by 6% YoY

Dividends

What is SYK's dividend history
DPS
$2.47
Dividend yield
0.9%
Payout ratio
44.5%
Recent dividends

Financial health

How did Stryker financials performed over time
The total assets is 70% greater than the total liabilities
SYK's quick ratio is down by 41% YoY and by 4.8% from the previous quarter
The current ratio has declined by 27% year-on-year and by 7% since the previous quarter
SYK's debt is 8% less than its equity
The debt to equity has contracted by 9% YoY and by 5% from the previous quarter
SYK's equity is up by 8% year-on-year and by 2.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.